Wockhardt stock gains 3% as it receives GMP certificate from UK health regulator

Shares of Wockhardt gained over 3 per cent in trade on Wednesday after the drug firm received a good manufacturing practice (GMP) certificate from the UK health regulator after an inspection at its Chikalthana plant at Aurangabad in Maharashtra.
 
The stock surged as much as Rs 1748.20, up 3.40 per cent on the Bombay Stock Exchange (BSE).

"The company has undergone recently an inspection at its L1-Chikalthana, Aurangabad manufacturing facility by UK MHRA and has received a communication confirming the closure of the inspection and issuance of an unrestricted GMP certificate", Wockhardt said in a filing to BSE.

In October, Wockhardt had informed bourses that United Kingdom Medicines and Healthcare Products Regulatory Agency (UKMHRA) has completed inspection of its Chikalthana plant without issuing any critical observations on the facility.

The UK regulator had in October 2013 withdrawn the GMP certificate to the Chikalthana plant and had also initiated recall of five prescription medicines from there.